Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Arcutis Biotherapeutics, Inc. (ARQT) had Non-Operating Income/Expense of $-1.04M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$99.22M |
|
$7.41M |
|
$8.69M |
|
$90.53M |
|
$90.69M |
|
$8.53M |
|
|
Non-Operating Income/Expense |
$-1.04M |
$7.49M |
|
$7.49M |
|
$7.41M |
|
$7.41M |
|
$7.41M |
|
$7.41M |
|
$8.53M |
|
$8.54M |
|
127.62M |
|
132.88M |
|
$0.06 |
|
$0.06 |
|
| Balance Sheet Financials | |
$349.22M |
|
$1.22M |
|
$21.75M |
|
$370.98M |
|
$99.77M |
|
$107.50M |
|
$113.13M |
|
$212.90M |
|
$158.07M |
|
$142.70M |
|
$158.07M |
|
120.29M |
|
| Cash Flow Statement Financials | |
$-31.81M |
|
$3.93M |
|
$3.25M |
|
$71.95M |
|
$47.43M |
|
$-24.52M |
|
$30.30M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.50 |
|
-- |
|
-- |
|
0.40 |
|
0.69 |
|
91.25% |
|
8.59% |
|
8.59% |
|
-- |
|
7.55% |
|
7.47% |
|
$-32.50M |
|
-- |
|
-- |
|
-- |
|
0.27 |
|
0.39 |
|
0.86 |
|
104.42 |
|
4.69% |
|
5.19% |
|
2.00% |
|
2.79% |
|
$1.31 |
|
$-0.24 |
|
$-0.24 |
|